S. Crunkhorn, Anticancer drugs: Redesigning kinase inhibitors, février 2008, Nature Revs Drug Discovery, 7:120-121 doi 10.1038/nrd2524 [4]
nih.gov
ncbi.nlm.nih.gov
A. Fernández, R. Scott, Dehydron: a structurally encoded signal for protein interaction, Biophys J, 2003 Sep;85(3):1914-28. PMID12944304[1]
A. Fernández, R. Scott, Adherence of packing defects in soluble proteins, Phys Rev Lett, 2003 91(1):018102. PMID12906578[2]
G. D. Demetri, Structural reengineering of imatinib to decrease cardiac risk in cancer therapy, 3 décembre 2007, J Clin Invest, 117(12):3650–3653. doi 10.1172/JCI34252 [6]
J. Boyd, Drug design: New book introduces fresh approach, 28 avril 2010 [5]
uchicago.edu
www-news.uchicago.edu
S. Koppes, Discovery of new sticky force that binds proteins could lead to better drug design, 2 juillet 2003 dehydron
warf.org
Wisconsin Alumni Research Foundation, Invention: Treating Heart Failure by Inhibiting Myosin Interaction with a Regulatory Myosin Binding Protein (US patent no 9051387), Inventors: Richard L. Moss and Ariel Fernandez [8]